Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
Scientists hoping to get more diversity of ancestry among medical research volunteers need to grapple with the history of medical exploitation, says a Columbia University bioethicist.
A young cancer doctor uses social media to skewer what he sees as overblown claims for "precision medicine." That doesn't make him hugely popular at cancer research meetings.
An experimental therapy seems to have eradicated cancer in a patient with metastatic breast cancer who had failed every other treatment. The goal is to reliably repeat that success in more people.
Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.
The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.
Hundreds of millions of dollars are pouring into research labs in an effort to collect genetic information on a million people. But some skeptics say the focus should be on humans themselves, not DNA.
An influential Harlem church is trying to help the National Institutes of Health overcome reluctance by some African-Americans to participate in a medical study of 1 million diverse Americans.
Most people's doctors put their health information in an electronic health record. Scientists are mining those records for clues to what treatments work best for individuals.
Doctors and scientists could could learn a lot more about diseases if the were able to to tap into a wide spectrum of information about people who get sick and those who stay healthy.